Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Journal article
Folegatti PM. et al, (2021), Vaccines, 9, 262 - 262
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.
Journal article
Wilkie M. et al, (2020), Vaccine, 38, 779 - 789
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
Journal article
Manjaly Thomas Z-R. et al, (2019), PLoS medicine, 16
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
Journal article
Venkatraman N. et al, (2019), The Journal of Infectious Diseases, 219, 1187 - 1197
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 33 - 33
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
Journal article
Tiono AB. et al, (2018), PLOS ONE, 13, e0208328 - e0208328
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
Journal article
Bliss CM. et al, (2018), Scientific Reports, 8
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
Journal article
Jin J. et al, (2018), npj Vaccines, 3
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
Journal article
Rampling T. et al, (2018), npj Vaccines, 3
Prime and target immunization protects against liver-stage malaria in mice
Journal article
Gola A. et al, (2018), Science Translational Medicine, 10, eaap9128 - eaap9128
Corrigendum to “Heterologous Two-dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-lasting Cellular Immunity to Influenza Virus A in Healthy Adults” [EBioMedicine 29 (2018) 146–154]
Journal article
Coughlan L. et al, (2018), EBioMedicine, 31, 321 - 321
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
Journal article
Coughlan L. et al, (2018), EBioMedicine, 29, 146 - 154
"PRIME-TARGET" IMMUNIZATION WITH VIRAL VECTORS FOR ENHANCED EFFICACY OF LIVER-STAGE MALARIA VACCINES
Conference paper
Ewer K. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 585 - 585
EFFICACY OF THE NOVEL PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE RH5.1/AS01B IN A PHASE I/IIA CLINICAL TRIAL
Conference paper
Minassian A. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 581 - 582
Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A.
Journal article
Wajja A. et al, (2018), Wellcome open research, 3
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
Journal article
Mensah VA. et al, (2017), Frontiers in Immunology, 8
Abstract Book
Conference paper
(2017), The American Journal of Tropical Medicine and Hygiene, 97, 1 - 10
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Journal article
Payne RO. et al, (2017), JCI Insight, 2